Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Angiotensin II Level in Chronic Hepatitis C Patients After SVR with Direct-Acting Antivirals
TCTR20161025001Enrolling by invitation
- Sponsor
- N/A
- Start
- Oct 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in hepatitis C virus infection, sponsored by N/A. Primary endpoint: Serum angiotensin II level. Started Oct 2016; status: enrolling by invitation.
02
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on TCTR20161025001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161025001.